Taking A Look At CymaBay Therapeutics Inc (CBAY)'s Big Deal
CymaBay Therapeutics Inc (NASDAQ:CBAY) is running up on the news that it has scored an exclusive licensing agreement with Kowa Pharmaceuticals America, Inc.
Cymabay Therapeutics Inc. (CBAY)
Market is closed
News
- First
- << Previous
- 21 - 27
Here's Why Apple, Tesla, and Three Other Stocks Are Trending
With the new investing year having just begun, plenty of meaningful events have caused major stocks such as Apple Inc.
Corporate Insiders at Alcoa Inc. (AA) and Two Other Battered Companies Keep Buying Shares
The insider buying activity in the past several weeks has been muted ahead of the first-quarter earnings season. However, aluminum producer Alcoa Inc.
Actuant Corporation (ATU) and 2 Other Battered Companies Receive a Vote of Confidence from Insiders
Aside from analyzing the financials of companies, which involves the analysis of their balance sheets and quarterly earnings reports, some investors also monitor insider trading behavior to find hints...
Is CymaBay Therapeutics Inc (CBAY) A Good Stock To Buy?
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
Lumber Liquidators Holdings Inc (LL): Steve Cohen’s Point72 Seems To Love This Stock
Steve Cohen’s Point72 Asset Management disclosed today a huge increase in its stake in Lumber Liquidators Holdings Inc (NYSE:LL). The funds affiliated with Mr.
Why Steve Cohen Added CymaBay Therapeutics Inc (CBAY) to His Portfolio?
CymaBay Therapeutics Inc (NASDAQ:CBAY) has been recently added to Steve Cohen's equity portfolio, as a new filing with the Securities and Exchange Commission revealed. Mr.
- First
- << Previous
- 21 - 27
Billionaire Hedge Funds
